FlowCam Used to Study Intravitreal Anti-VEGF Drugs: Particle Burden and Protein Aggregates

FlowCam Used to Study Intravitreal Anti-VEGF Drugs: Particle Burden and Protein Aggregates

In a recent paper discussing particle counting and analytical techniques, the number and type of particles present in intravitreal injection formulations of three different drug agents used against vascular endothelial growth factor were investigated.

Total visible, subvisible and nanoparticle numbers along with size distributions were quantified using light obscuration, flow imaging microscopy, resonant mass measurement, tunable resistive pulse sensing, and dynamic light scattering.

The goal of the study was to contribute data on levels of subvisible particles, nanoparticles, and protein aggregates in the new prefilled aflibercept and brolucizumab syringes and to compare it to samples of bevacizumab delivered from a compounding pharmacy.

Of particular interest is the yet undetermined role of nanoparticles in ophthalmic  solutions, and the potential to contribute to interocular pressure (IOP). It is not known whether nano- or microparticles, or the proteins themselves cause a blockage of the trabecular meshwork. Prior research has clearly demonstrated that secondary IOP increase can be due to mechanical obstruction of the trabecular meshwork.

The team performed the study using a FlowCam 8100, suitable for particles 2µm - 100µm. The FlowCam Nano is also now available, enabling the count and characterization of particles as small as 300nm.

Read the full paper here:

M. Schargus, K.T. Kopp, C. Helbig, A. Frings, G. Winter "Comparison of Syringes With Intravitreal Anti-VEGF Drugs: Particle Burden and Protein Aggregates in Brolucizumab, Aflibercept and Bevacizumab" Translational Vision Science & Technology, August 2021, https://doi.org/10.1167/tvst.10.9.21

Post Topics

Related Posts

Nurse with IV bag and patient in the background
Monitoring Subvisible Particle Formation in Infusion Bags Exposed to Stress Conditions
Agitation during transportation is one of the most ubiquitous stress conditions to which therapeutic protein formulations and other biotherapeutic …
Read Post
FlowCam images of IVIG proteins before and after drop shock
Study Uses FlowCam to Investigate Effects of Diluent and Silicone Oil on Particulate Formation in IV Bags
Protein aggregation is a major concern for biopharmaceuticals in post-production. Subvisible particles that form due to routine handling compromise …
Read Post
Need Supplies?

Find supplies and spare parts for your FlowCam instrument or ask for a quote. 

Order Now

Need Help?

Get technical support and application help. Request training or preventative maintenance.


Submit a Support Ticket

Need Information?

Check out our knowledge base including white papers, application notes, technical notes, and videos.

View Resources